September 9 – 12, 2019

Westin Boston Waterfront

Boston, MA


Simplifying the Emerging Biomarker Paradigm in Immuno-Oncology

Wednesday October 3 | 1:30pm – 5pm

The immuno-oncology field is rapidly evolving, with biomarkers taking a leading role in clinical care and implementation. The use of biomarkers in cancer treatment has allowed for increased patient segmentation, but as the number of biomarkers and complexity of testing continue to grow – simplification will be of increasing importance.

Please Join Bristol-Myers Squibb and their expert panel of speakers in this interactive and in-depth workshop, as these leaders in the field discuss and brainstorm potential solutions to these complex considerations.